JCPenney Gets $2.25...
Health Care: Drugs
MannKind Corporation (MNKD: NASDAQ)
$6.85 0.62 | 9.95%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 61.84M | 2.68M | 66.06M | 30.02M |
| Receivables | 450.00K | 0.00 | 674.00K | 1.50M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 66.81M | 5.82M | 73.95M | 37.67M |
| Property, Plant & Equipment, Gross | 285.21M | 284.79M | 283.75M | 273.97M |
| Accumulated Depreciation & Depletion | 101.25M | 91.76M | 81.39M | 65.74M |
| Property, Plant & Equipment, Net | 183.96M | 193.03M | 202.36M | 208.23M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 543.00K | 703.00K | 946.00K | 1.50M |
| Total Non-Current Assets | 184.50M | 193.73M | 203.30M | 209.73M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 251.31M | 199.55M | 277.26M | 247.40M |
| Accounts Payable | 4.56M | 4.62M | 3.29M | 6.52M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 144.78M | 25.36M | 18.13M | 28.85M |
| Long Term Debt | 217.22M | 487.84M | 444.65M | 277.76M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 217.22M | 487.84M | 444.65M | 277.76M |
| Total Liabilities | 361.99M | 513.20M | 462.79M | 306.62M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -110.68M | -313.65M | -185.53M | -59.22M |
| Common Par | 2.86M | 1.32M | 1.28M | 1.13M |
| Additional Paid In Capital | 1.99B | 1.62B | 1.59B | 1.54B |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -2.10B | -1.94B | -1.77B | -1.60B |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -6.00K | 44.00K | 74.00K | -281.00K |
| Total Capitalization | 106.54M | 174.19M | 259.12M | 218.54M |
| Total Equity | -110.68M | -313.65M | -185.53M | -59.22M |
| Total Liabilities & Stock Equity | 251.31M | 199.55M | 277.26M | 247.40M |
| Total Common Shares Outstanding | 286.04M | 131.52M | 127.79M | 113.03M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 180.86M | 121.82M | 113.67M | 106.53M |
| Diluted Weighted Shares Outstanding | 180.86M | 121.82M | 113.67M | 106.53M |
| Number of Employees | 246 | 250 | 436 | 443 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with MNKD
- Portfolio NameUser Type
- ContributorMost-Active Stocks for the ...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- Userbiomed
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserHoldings
- Contributor10 Most Shorted Stocks in B...
Latest MNKD Headlines from TheStreet
- Commit To Buy MannKind Corp At $2.50, Earn 28% 05.23.13 | 02:05 pm
- MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It 04.17.13 | 09:04 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- 3 Highly Shorted Stocks Under $5 Bought Up By Hedge Funds 04.09.13 | 01:04 pm
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- 8 Stocks Under $5 Seeing Institutional And Insider Buying 04.02.13 | 03:04 pm
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
- These 3 Insider Favorites Are Trading Significantly Below Target Price 01.14.13 | 12:01 pm
- Biotech 2013 Kickoff Party: J.P. Morgan Investor Confab 01.04.13 | 08:01 am
Press Releases for MNKD
- MannKind Corporation To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 05:02 pm
- MannKind Corporation Reports 2012 Fourth Quarter And Full Year Financial Results - Business Wire 02.11.13 | 04:02 pm
- MannKind Corporation To Hold 2012 Fourth Quarter And Full Year Financial Results Conference Call On February 11, 2013 - Business Wire 02.04.13 | 05:02 pm
- MannKind Corporation To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.03.13 | 05:01 pm
- MannKind Corporation To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 05:11 pm
- Faruqi & Faruqi, LLP Launches An Investigation Against Mannkind Corp. (MNKD) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors - Business Wire 11.19.12 | 07:11 pm
- Colby And MannKind Sign License And Joint Development Agreement To Develop And Commercialize Cancer Immunotherapy Products - Business Wire 11.13.12 | 08:11 am
- MannKind Corporation Reports 2012 Third Quarter Financial Results - Business Wire 11.01.12 | 04:11 pm
- MannKind Corporation Reschedules 2012 Third Quarter Financial Results Conference Call To November 1, 2012 Due To Hurricane Sandy - Business Wire 10.29.12 | 02:10 pm
- MannKind Corporation To Hold 2012 Third Quarter Financial Results Conference Call On October 29, 2012 - Business Wire 10.22.12 | 06:10 pm
Partner Headlines for MNKD
- Mid-Afternoon Market Update: Markets Remain Down, Bankrate Rallies - Benzinga 04.12.13 | 03:04 pm
- Long MannKind's Afrezza: Shares Versus A Bull Call Spread - Seeking Alpha 12.01.12 | 07:12 am
- MannKind to Raise Funds - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- MannKind Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga 10.18.12 | 09:10 am
- MNKD Enrolls Patients for Afrezza - Analyst Blog - Zacks 10.08.12 | 06:10 pm
- Company News for September 05, 2012 - Corporate Summary - NASDAQ 09.05.12 | 02:09 pm
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly Top Insider Buys: HRB, LPI, GCO, GAM, SONC, MNKD - GuruFocus 07.09.12 | 01:07 pm
- A123 Systems POPS to Lead 7 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.21.12 | 11:06 am
- MNKD Cancer Treatment Data Released - Analyst Blog - Zacks 06.01.12 | 06:06 pm
